CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer

Human epidermal growth factor receptor 2-positive (HER2+) breast cancer is characterized by invasive growth, rapid metastasis and chemoresistance. Trastuzumab is an effective treatment for HER2+ breast cancer; however, trastuzumab resistance leads to cancer relapse and metastasis. CKLF-like MARVEL t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Fei, Gao, Hongli, Chen, Guanglei, Sun, Lisha, Sun, Jiayi, Qiao, Xinbo, Xue, Jinqi, Liu, Caigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830830/
https://www.ncbi.nlm.nih.gov/pubmed/36627608
http://dx.doi.org/10.1186/s12943-023-01716-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830830/
https://www.ncbi.nlm.nih.gov/pubmed/36627608
http://dx.doi.org/10.1186/s12943-023-01716-y

Ejemplares similares